lamivudine oral

FDA Drug Profile — lamivudine

Drug Details

Generic Name
lamivudine oral
Brand Names
lamivudine
Application Number
ANDA203564
Sponsor
Chartwell RX, LLC
NDC Codes
2
Dosage Forms
SOLUTION
Routes
ORAL
Active Ingredients
LAMIVUDINE

Indications and Usage

1 INDICATIONS AND USAGE Lamivudine oral solution, USP is a nucleoside analogue indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Limitations of Use: The dosage of this product is for HIV-1 and not for HBV. Lamivudine oral solution, USP is a nucleoside analogue reverse transcriptase inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. Limitations of Use: The dosage of this product is for HIV-1 and not for HBV. ( 1 )